MOR Wealth Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.97M Buy
314,905
+12,458
+4% +$100K 1.12% 19
2026
Q2
$2.65M Buy
302,447
+19,200
+7% +$145K 1.05% 20
2026
Q1
$2.17M Buy
283,247
+33,982
+14% +$233K 1% 20
2025
Q4
$494K Buy
+249,265
New +$565K 0.23% 58

Other funds holding IBRX

MOR Wealth Management's IBRX Position: Q3 2026 in Review

MOR Wealth Management increased its ImmunityBio (IBRX) stake by 4.1% in Q3 2026, buying an estimated $100K and bringing the position to 314,905 shares worth $2.97M. The position accounts for 1.12% of the portfolio, ranked #19.

MOR Wealth Management first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • MOR Wealth Management held 314,905 shares of ImmunityBio worth $2.97M as of Q3 2026.
  • MOR Wealth Management bought 12,458 ImmunityBio shares in Q3 2026, an estimated $100K.
  • ImmunityBio made up 1.12% of MOR Wealth Management's portfolio in Q3 2026, its #19 holding.
  • MOR Wealth Management first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
  • 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.